- Home
- CMPX vs MHN Comparison
CMPX vs MHN Comparison
Compare CMPX & MHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- MHN
- Stock Information
- Founded
- CMPX 2014
- MHN 1997
- Country
- CMPX United States
- MHN United States
- Employees
- CMPX N/A
- MHN N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- MHN Investment Bankers/Brokers/Service
- Sector
- CMPX Health Care
- MHN Finance
- Exchange
- CMPX Nasdaq
- MHN Nasdaq
- Market Cap
- CMPX 291.8M
- MHN 293.6M
- IPO Year
- CMPX N/A
- MHN N/A
- Fundamental
- Price
- CMPX $3.51
- MHN $10.26
- Analyst Decision
- CMPX Strong Buy
- MHN
- Analyst Count
- CMPX 8
- MHN 0
- Target Price
- CMPX $13.50
- MHN N/A
- AVG Volume (30 Days)
- CMPX 876.2K
- MHN 59.2K
- Earning Date
- CMPX 11-11-2025
- MHN 01-01-0001
- Dividend Yield
- CMPX N/A
- MHN 4.17%
- EPS Growth
- CMPX N/A
- MHN N/A
- EPS
- CMPX N/A
- MHN N/A
- Revenue
- CMPX N/A
- MHN N/A
- Revenue This Year
- CMPX N/A
- MHN N/A
- Revenue Next Year
- CMPX N/A
- MHN N/A
- P/E Ratio
- CMPX N/A
- MHN N/A
- Revenue Growth
- CMPX N/A
- MHN N/A
- 52 Week Low
- CMPX $1.27
- MHN $8.69
- 52 Week High
- CMPX $4.08
- MHN $10.81
- Technical
- Relative Strength Index (RSI)
- CMPX 59.49
- MHN 76.22
- Support Level
- CMPX $3.37
- MHN $10.08
- Resistance Level
- CMPX $3.77
- MHN $10.25
- Average True Range (ATR)
- CMPX 0.19
- MHN 0.09
- MACD
- CMPX 0.01
- MHN 0.06
- Stochastic Oscillator
- CMPX 46.87
- MHN 98.67
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About MHN Blackrock MuniHoldings New York Quality Fund Inc.
BLACKROCK MUNIHOLDINGS NEW YORK QUALITY FUND, INC. is a closed-ended management investment company. The fund's investment objective is to provide shareholders with current income exempt from federal income tax and New York State and New York City personal income taxes.